Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade

por Yoshida, Takashi, Ohe, Chisato, Ikeda, Junichi, Atsumi, Naho, Ohsugi, Haruyuki, Sugi, Motohiko, Higasa, Koichiro, Saito, Ryoichi, Tsuta, Koji, Matsuda, Tadashi, Kinoshita, Hidefumi
Publicado 2021

Integration of NRP1, RGS5, and FOXM1 expression, and tumour necrosis, as a postoperative prognostic classifier based on molecular subtypes of clear cell renal cell carcinoma

por Yoshida, Takashi, Ohe, Chisato, Ikeda, Junichi, Atsumi, Naho, Saito, Ryoichi, Taniguchi, Hisanori, Ohsugi, Haruyuki, Sugi, Motohiko, Tsuta, Koji, Matsuda, Tadashi, Kinoshita, Hidefumi
Publicado 2021

Multicenter phase II study of FOLFIRI plus bevacizumab after discontinuation of oxaliplatin-based regimen for advanced or recurrent colorectal cancer (CR0802)

por Suenaga, Mitsukuni, Nishina, Tomohiro, Mizunuma, Nobuyuki, Yasui, Hisateru, Ura, Takashi, Denda, Tadamichi, Ikeda, Junichi, Esaki, Taito, Nishisaki, Hogara, Takano, Yoshinao, Sugiyama, Yasuyuki, Muro, Kei
Publicado 2015

PBRM1 Immunohistochemical Expression Profile Correlates with Histomorphological Features and Endothelial Expression of Tumor Vasculature for Clear Cell Renal Cell Carcinoma

por Saiga, Kazuho, Ohe, Chisato, Yoshida, Takashi, Ohsugi, Haruyuki, Ikeda, Junichi, Atsumi, Naho, Noda, Yuri, Yasukochi, Yoshiki, Higasa, Koichiro, Taniguchi, Hisanori, Kinoshita, Hidefumi, Tsuta, Koji
Publicado 2022

Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes

por Ohe, Chisato, Yoshida, Takashi, Ikeda, Junichi, Tsuzuki, Toyonori, Ohashi, Riuko, Ohsugi, Haruyuki, Atsumi, Naho, Yamaka, Ryosuke, Saito, Ryoichi, Yasukochi, Yoshiki, Higasa, Koichiro, Kinoshita, Hidefumi, Tsuta, Koji
Publicado 2022